Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10.

Leung G, Wang A, Fernando M, Phan VC, McKay DM.

Am J Physiol Gastrointest Liver Physiol. 2013 May 1;304(9):G781-92. doi: 10.1152/ajpgi.00055.2013. Epub 2013 Mar 14.

2.

In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice.

Hunter MM, Wang A, Parhar KS, Johnston MJ, Van Rooijen N, Beck PL, McKay DM.

Gastroenterology. 2010 Apr;138(4):1395-405. doi: 10.1053/j.gastro.2009.12.041. Epub 2010 Jan 4.

PMID:
20044996
3.
4.

Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages.

Rizzo A, Monteleone I, Fina D, Stolfi C, Caruso R, Fantini MC, Franzè E, Schwendener R, Pallone F, Monteleone G.

Inflamm Bowel Dis. 2012 Mar;18(3):449-59. doi: 10.1002/ibd.21799. Epub 2011 Jun 17.

PMID:
21688353
5.

Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis.

Mazzon E, Puzzolo D, Caputi AP, Cuzzocrea S.

Mol Med. 2002 Jul;8(7):353-66.

6.

Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus.

Ghia JE, Galeazzi F, Ford DC, Hogaboam CM, Vallance BA, Collins S.

Am J Physiol Gastrointest Liver Physiol. 2008 Mar;294(3):G770-7. doi: 10.1152/ajpgi.00453.2007. Epub 2008 Jan 17.

7.

IL-33-induced alternatively activated macrophage attenuates the development of TNBS-induced colitis.

Tu L, Chen J, Xu D, Xie Z, Yu B, Tao Y, Shi G, Duan L.

Oncotarget. 2017 Apr 25;8(17):27704-27714. doi: 10.18632/oncotarget.15984.

8.

Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages.

Reyes JL, Wang A, Fernando MR, Graepel R, Leung G, van Rooijen N, Sigvardsson M, McKay DM.

J Immunol. 2015 Jan 1;194(1):364-78. doi: 10.4049/jimmunol.1400738. Epub 2014 Dec 1.

9.

Allergic airway disease is unaffected by the absence of IL-4Rα-dependent alternatively activated macrophages.

Nieuwenhuizen NE, Kirstein F, Jayakumar J, Emedi B, Hurdayal R, Horsnell WG, Lopata AL, Brombacher F.

J Allergy Clin Immunol. 2012 Sep;130(3):743-750.e8. doi: 10.1016/j.jaci.2012.03.011. Epub 2012 Apr 30.

PMID:
22552110
10.

Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice.

Johnston MJ, Wang A, Catarino ME, Ball L, Phan VC, MacDonald JA, McKay DM.

Infect Immun. 2010 Mar;78(3):1364-75. doi: 10.1128/IAI.01349-08. Epub 2009 Dec 22.

11.

Erythropoietin reduces the development of experimental inflammatory bowel disease.

Cuzzocrea S, Mazzon E, Di Paola R, Patel NS, Genovese T, Muià C, De Sarro A, Thiemermann C.

J Pharmacol Exp Ther. 2004 Dec;311(3):1272-80. Epub 2004 Aug 9.

12.
13.

Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.

Bamba S, Lee CY, Brittan M, Preston SL, Direkze NC, Poulsom R, Alison MR, Wright NA, Otto WR.

J Pathol. 2006 Jun;209(2):265-73.

PMID:
16550633
14.

Thalidomide treatment reduces colon injury induced by experimental colitis.

Mazzon E, Muià C, Di Paola R, Genovese T, De Sarro A, Cuzzocrea S.

Shock. 2005 Jun;23(6):556-64.

PMID:
15897810
15.

Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice.

Melon A, Wang A, Phan V, McKay DM.

J Biomed Biotechnol. 2010;2010:384523. doi: 10.1155/2010/384523.

16.

Role of iNOS in hepatocyte tight junction alteration in mouse model of experimental colitis.

Mazzon E, Cuzzocrea S.

Cell Mol Biol (Noisy-le-grand). 2003 Feb;49(1):45-57.

PMID:
12839336
17.

Triggering immunological memory against the tapeworm Hymenolepis diminuta to protect against colitis.

Wang A, Arai T, Campbell A, Reyes JL, Lopes F, McKay DM.

Parasite Immunol. 2017 Nov;39(11). doi: 10.1111/pim.12490. Epub 2017 Oct 4.

PMID:
28892562
18.

5-lipoxygenase modulates the alteration of paracellular barrier function in mice ileum during experimental colitis.

Mazzon E, Sautebin L, Caputi AP, Cuzzocrea S.

Shock. 2006 Apr;25(4):377-83.

PMID:
16670640
19.

Cryopreserved IL-4-treated macrophages attenuate murine colitis in an integrin β7-dependent manner.

Leung G, Petri B, Reyes JL, Wang A, Iannuzzi J, Mckay DM.

Mol Med. 2015 Dec 9. doi: 10.2119/molmed.2015.00193. [Epub ahead of print]

20.

Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.

Guan Q, Ma Y, Hillman CL, Qing G, Ma AG, Weiss CR, Zhou G, Bai A, Warrington RJ, Bernstein CN, Peng Z.

Mol Med. 2011;17(7-8):646-56. doi: 10.2119/molmed.2010.00252. Epub 2011 Mar 11.

Supplemental Content

Support Center